CDH1 and non-small cell lung carcinoma: Figures 5, 8 present that downregulation of ALKBH5 or p53 significantly decreased Sox2 and increased E-cadherin protein levels, which is consistent with our previous findings and demonstrated the upstream regulating roles of ALKBH5 in modulating malignancies of CSCs derived from NSCLC.